HuGE Literature Finder
Records
1
-
30
| A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib. BMC medical genomics 2022 Jun 15 (1): 141. Chen Yan, Jiang Bo, He Yuange, Zhang Chu, Zhou Wenjie, Fang Cheng, Gu Dejian, Zhang Minxia, Ji Mei, Shi Juntao, Yang X |
| Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients. Cancer medicine 2022 Jun . Tian Hong-Xia, Chen Zhi-Hong, Jie Guang-Ling, Wang Zhen, Yan Hong-Hong, Wu Si-Pei, Zhang Shui-Lian, Lu Dan-Xia, Zhang Xu-Chao, Wu Yi-Lo |
| Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing. BMC cancer 2022 May 22 (1): 580. Yang Hainan, Wen Lei, Pan Yingying, Shan Changguo, Hong Weiping, Wang Hui, Zhou Cheng, Cai Linbo, Zhou Caic |
| Evaluation of the Mutation Profile via Next-Generation Sequencing in a Turkish Population With Non-small Cell Lung Cancer. Balkan medical journal 2021 Nov 38 (6): 382-391. Kahraman Çetin Nesibe, Erdo?du ?brahim Halil, Bozkurt Emin, Meteo?lu ?brah |
| Microsatellite Instability Is Rare in the Admixed Brazilian Population of Non-Small Cell Lung Cancer: A Cohort of 526 Cases. Pathobiology : journal of immunopathology, molecular and cellular biology 2021 Nov 1-6. De Marchi Pedro, Berardinelli Gustavo Noriz, Cavagna Rodrigo de Oliveira, Pinto Icaro Alves, da Silva Flavio Augusto Ferreira, Duval da Silva Vinicius, Santana Iara Viana Vidigal, da Silva Eduardo Caetano Albino, Ferro Leal Leticia, Reis Rui Manu |
| The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocrine-related cancer 2021 Oct . Venizelos Andreas, Elvebakken Hege, Perren Aurel, Nikolaienko Oleksii, Deng Wei, Lothe Inger Marie B, Couvelard Anne, Hjortland Geir Olav, Sundlöv Anna, Svensson Johanna B, Garresori Harrish, Kersten Christian, Hofsli Eva, Detlefsen Sonke, Krogh Merete, Sorbye Halfdan, Knappskog Sti |
| Co-mutations of epidermal growth factor receptor and BRAF in Chinese non-small cell lung cancer patients. Annals of translational medicine 2021 Aug 9 (16): 1321. Peng Panli, Lv Guoli, Hu Jinwei, Wang Kai, Lv Junhong, Guo Ga |
| Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis. Pathology, research and practice 2021 Jul 224 153551. Wu Yongfeng, Ni Heng, Yang Dexin, Niu Yuequn, Chen Kelie, Xu Jinming, Wang Fang, Tang Song, Shi Yu, Zhang Honghe, Hu Jian, Xia Dajing, Wu Yih |
| Retrospective analysis of eleven gene mutations, PD-L1 expression and clinicopathological characteristics in non-small cell lung cancer patients. Asian journal of surgery 2021 Jul . Liu Yanqing, Wu Aihua, Li Xinjian, Wang Shanshan, Fang Shuyu, Mo Yij |
| Modeling clinical responses to targeted therapies by patient-derived organoids of advanced lung adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 Jun . Kim Seok-Young, Kim Sang-Min, Lim Sumin, Lee Ji Yeon, Choi Su-Jin, Yang San-Duk, Yun Mi Ran, Kim Chang Gon, Gu Seo Rin, Park Chae-Won, Park A-Young, Lim Sun Min, Heo Seong Gu, Kim Hyunki, Cho Byoung Ch |
| BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy. European journal of cancer (Oxford, England : 1990) 2021 May 149 211-221. Wiesweg Marcel, Preuß Cedric, Roeper Julia, Metzenmacher Martin, Eberhardt Wilfried, Stropiep Ursula, Wedeken Katrin, Reis Henning, Herold Thomas, Darwiche Kaid, Aigner Clemens, Stuschke Martin, Schildhaus Hans-Ulrich, Schmid Kurt W, Falk Markus, Heukamp Lukas, Tiemann Markus, Griesinger Frank, Schuler Mart |
| NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment. Molecular oncology 2021 May . Sánchez-Herrero Estela, Serna-Blasco Roberto, Ivanchuk Vadym, García-Campelo Rosario, Dómine Gómez Manuel, Miguel Sánchez José, Massutí Bartomeu, Reguart Noemi, Camps Carlos, Sanz-Moreno Sandra, Calabuig-Fariñas Silvia, Jantus-Lewintre Eloísa, Arnal Magdalena, Fernández-Orth Dietmar, Calvo Virginia, González-Rumayor Víctor, Provencio Mariano, Romero Atoc |
| Prevalence of Targetable Mutations in Black Patients With Lung Cancer: A Systematic Review and Meta-Analysis. JCO oncology practice 2021 May 17 (5): e629-e636. Costa Philippos A, Saul Eduardo E, Paul Yonette, Iyer Sunil, da Silva Laercio Lopes, Tamariz Leonardo, Lopes Gilber |
| Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical field. Lung cancer (Amsterdam, Netherlands) 2021 Apr 154 131-141. Volckmar Anna-Lena, Christopoulos Petros, Kirchner Martina, Allgäuer Michael, Neumann Olaf, Budczies Jan, Rempel Eugen, Horak Peter, Glade Julia, Goldschmid Hannah, Seker-Cin Huriye, Brandt Regine, Kriegsmann Mark, Leichsenring Jonas, Winter Hauke, Faehling Martin, Fischer Jürgen R, Heußel Claus Peter, Herth Felix, Brummer Tilman, Fröhling Stefan, Schirmacher Peter, Thomas Michael, Endris Volker, Penzel Roland, Kazdal Daniel, Bochtler Tilmann, Stenzinger Albrec |
| Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients with Non-Small Cell Lung Cancer. Chest 2021 Apr . Roosan Moom R, Mambetsariev Isa, Pharaon Rebecca, Fricke Jeremy, Husain Hatim, Reckamp Karen L, Koczywas Marianna, Massarelli Erminia, Bild Andrea H, Salgia Ra |
| Crizotinib in Patients With MET-Amplified NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Mar . Camidge D Ross, Otterson Gregory A, Clark Jeffrey W, Ignatius Ou Sai-Hong, Weiss Jared, Ades Steven, Shapiro Geoffrey I, Socinski Mark A, Murphy Danielle A, Conte Umberto, Tang Yiyun, Wang Sherry C, Wilner Keith D, Villaruz Liza |
| Morphological and genetic heterogeneity of synchronous multifocal lung adenocarcinoma in a Chinese cohort. BMC cancer 2021 Feb 21 (1): 176. Zhu Donglin, Cao Dan, Shen Minghong, Lv Jinghu |
| [A Real-world Study on the Assessment of Pathological Characteristics and Targeted Therapeutic Effect of Non-small Cell Lung Cancer Patients with Positive Driving Genes and High PD-L1 Expression]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2021 Jan . Zhang Hui, Yang Xinjie, Li Kun, Wang Jinghui, Lv Jialin, Li Xi, Zhang Xinyong, Qin Na, Zhang Quan, Wu Yuhua, Ma Li, Gai Fei, Hu Ying, Zhang Shuc |
| Evaluation on the Distribution of EGFR, KRAS and BRAF Genes and the Expression of PD-L1 in Different Types of Lung Cancer. International journal of general medicine 2021 14 5615-5620. Zhao Rui, Gao Shan, He Haiqi, Zhang Jia, Zhang Guangjian, Wen Xiaope |
| Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China. Frontiers in oncology 2021 11 630717. Lv Weize, Cheng Hua, Shao Di, Wei Yajun, Zhu Weiping, Wu Kui, Jiang Wenxi, Hu Liyang, Sha Zhou, Zhong Beilong, Pei Xiaofe |
| Comprehensive genomic profiling of Brazilian non-small cell lung cancer patients (GBOT 0118/LACOG0418). Thoracic cancer 2020 Dec . Mascarenhas Eldsamira, Gelatti Ana Caroline, Araújo Luiz Henrique, Baldotto Clarissa, Mathias Clarissa, Zukin Mauro, Werutsky Gustavo, Pacheco Patricia, Gomes Rafaela, de Castro Gilberto, de Lima Vladmir Cordei |
| The landscape of kinase domain duplication in Chinese lung cancer patients. Annals of translational medicine 2020 Dec 8 (24): 1642. Wu Di, Xie Yuancai, Jin Chang'e, Qiu Jinfan, Hou Ting, Du Haiwei, Chen Songan, Xiang Jianxing, Shi Xi, Liu Junli |
| Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA. EBioMedicine 2020 Nov 62 103103. Dietz Steffen, Christopoulos Petros, Yuan Zhao, Angeles Arlou Kristina, Gu Lisa, Volckmar Anna-Lena, Ogrodnik Simon J, Janke Florian, Fratte Chiara Dalle, Zemojtel Tomasz, Schneider Marc A, Kazdal Daniel, Endris Volker, Meister Michael, Muley Thomas, Cecchin Erika, Reck Martin, Schlesner Matthias, Thomas Michael, Stenzinger Albrecht, Sültmann Holg |
| KRAS G12C mutations in Asia: a landscape analysis of 11,951 Chinese tumor samples. Translational lung cancer research 2020 Oct 9 (5): 1759-1769. Loong Herbert Ho-Fung, Du Nan, Cheng Chunyan, Lin Hanqing, Guo Jian, Lin Gen, Li Mingjiang, Jiang Tao, Shi Zhihua, Cui Yanzhi, Jin Xianfeng, Yao Jicheng, Xing Yutong, Yao Ming, Wang Kai, Mok Tony S K, Liu Lun |
| The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2020 Aug . Caso Raul, Sanchez-Vega Francisco, Tan Kay See, Mastrogiacomo Brooke, Zhou Jian, Jones Gregory D, Nguyen Bastien, Schultz Nikolaus, Connolly James G, Brandt Whitney S, Bott Matthew J, Rocco Gaetano, Molena Daniela, Isbell James M, Liu Yuan, Mayo Marty W, Adusumilli Prasad S, Travis William D, Jones David |
| Clinical significance of tumor mutation burden and DNA damage repair in advanced stage non-small cell lung cancer patients. European review for medical and pharmacological sciences 2020 Jul 24 (14): 7664-7672. Zhang H, Deng Y-M, Chen Z-C, Tang Y-C, Yang S, Zhang S-D, Liang J-M, Wang Y-G, Wu X, Zhang R-W, Feng W |
| Differences in molecular epidemiology of lung cancer among ethnicities (Asian vs. Caucasian). Journal of thoracic disease 2020 Jul 12 (7): 3776-3784. Izumi Motohiro, Suzumura Tomohiro, Ogawa Koichi, Matsumoto Yoshiya, Sawa Kenji, Yoshimoto Naoki, Tani Yoko, Watanabe Tetsuya, Kaneda Hiroyasu, Mitsuoka Shigeki, Asai Kazuhisa, Kawaguchi Tomo |
| Status of 10 targeted genes of non-small cell lung cancer in eastern China: A study of 884 patients based on NGS in a single institution. Thoracic cancer 2020 Jul . Li Dan, Ding Li, Ran Wenwen, Huang Yan, Li Guangqi, Wang Chengqin, Xiao Yujing, Wang Xiaonan, Lin Dongliang, Xing Xiaomi |
| Molecular Analysis of Oncogenic Mutations in Resected Margins by Next-Generation Sequencing Predicts Relapse in Non-Small Cell Lung Cancer Patients. OncoTargets and therapy 2020 13 9525-9531. Wei Weitian, Li Xingliang, Song Mengmeng, Wang Changch |
| Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis. BioMed research international 2020 2020 2380124. Fan Kui, Zhang Chuan-Long, Qi Yuan-Fu, Dai Xin, Birling Yoann, Tan Zhao-Feng, Cao Fa |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 18, 2022
- Content source: